EUREKA celebrates 20-year R&D investment history:
This article was originally published in Clinica
Europe's international collaborative R&D, innovation and competitiveness investment programme, EUREKA, has invested E22bn ($28.5bn) in around 1,600 projects since its launch 20 years ago this month. There are currently some 680 projects in place, supported by funds totalling E1.9bn. The programme is claiming an important role in seeking to raise EU investment in R&D above a target threshold of 3% of GDP (for further information see: www.eureka-20years.net).
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.